Evidence map›Paper›PMID 39325028›Full record

ArticleMicrobial genomics2024

Genomic study substantiates the intensive care unit as a reservoir for carbapenem-resistant

Shuo Jiang, Zheng Ma, Huiluo Cao, Li Mo, Jinlan Jin, Bohai Yu, Kankan Chu, Jihua Hu

Abstract read
In one paragraph

Article in Microbial genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Enhancing the Antibacterial Activity of Endolysin againstJournal of microbiology and biotechnology · 2026
    Article
  2. Article
  3. Article
  4. Infection and drug resistance · 2026
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuo JiangShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.
Zheng MaShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.
Huiluo CaoDepartment of Microbiology, University of Hong Kong, Hong Kong, PR China.
Li MoShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.
Jinlan JinShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.
Bohai YuShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.
Kankan ChuShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.
Jihua HuShenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Shenzhen, Guangdong, PR China, Shenzhen, Guangdong, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

CarbapenemsHospitals, TeachingIntensive Care UnitsKlebsiella InfectionsKlebsiella pneumoniaeAgedAged, 80 and overAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeChinaCross InfectionFemaleGenome, BacterialGenome-Wide Association StudyGenomicsHumansAnti-Bacterial AgentsCarbapenemsantimicrobial resistanceCarbapenem-resistant Klebsiella pneumoniae (CRKP)hospital transmissionintensive care unit (ICU)

Identifiers

PMID39325028
PMCPMC11541224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.